Dopamine in Autism Spectrum Disorders—Focus on D2/D3 Partial Agonists and Their Possible Use in Treatment
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dopamine in Autism Spectrum Disorders—Focus on D2/D3 Partial Agonists and Their Possible Use in Treatment
Authors
Keywords
-
Journal
Frontiers in Psychiatry
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-02-03
DOI
10.3389/fpsyt.2021.787097
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exploring the structural basis and atomistic binding mechanistic of the selective antagonist blockade at D 3 dopamine receptor over D 2 dopamine receptor
- (2021) Patrick Appiah‐Kubi et al. JOURNAL OF MOLECULAR RECOGNITION
- Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders
- (2021) Béla Kiss et al. Biomolecules
- Cariprazine alleviates core behavioral deficits in the prenatal valproic acid exposure model of autism spectrum disorder
- (2021) Viktor Román et al. PSYCHOPHARMACOLOGY
- Cariprazine Safety in Adolescents and the Elderly: Analyses of Clinical Study Data
- (2020) Balázs Szatmári et al. Frontiers in Psychiatry
- Cariprazine as a treatment across the bipolar I spectrum from depression to mania: mechanism of action and review of clinical data
- (2020) Stephen M. Stahl et al. Therapeutic Advances in Psychopharmacology
- Genetic and Epigenetic Etiology Underlying Autism Spectrum Disorder
- (2020) Sang Hoon Yoon et al. Journal of Clinical Medicine
- P-cresol Alters Brain Dopamine Metabolism and Exacerbates Autism-Like Behaviors in the BTBR Mouse
- (2020) Tiziana Pascucci et al. Brain Sciences
- The Neurochemistry of Autism
- (2020) Rosa Marotta et al. Brain Sciences
- Altered dopaminergic pathways and therapeutic effects of intranasal dopamine in two distinct mouse models of autism
- (2020) Owen Y. Chao et al. Molecular Brain
- Autism Spectrum Disorder and Schizophrenia Are Better Differentiated by Positive Symptoms Than Negative Symptoms
- (2020) Dominic A. Trevisan et al. Frontiers in Psychiatry
- Pharmacology profile of F17464, a dopamine D3 receptor preferential antagonist
- (2020) Cristina Cosi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Dual-acting agents for improving cognition and real-world function in Alzheimer’s disease: Focus on 5-HT6 and D3 receptors as hubs
- (2020) Mark J. Millan et al. NEUROPHARMACOLOGY
- Autism-linked dopamine transporter mutation alters striatal dopamine neurotransmission and dopamine-dependent behaviors
- (2019) Gabriella E. DiCarlo et al. JOURNAL OF CLINICAL INVESTIGATION
- Keeping up with the therapeutic advances in schizophrenia: a review of novel and emerging pharmacological entities
- (2019) Amanda Krogmann et al. CNS SPECTRUMS
- The Role of Dopamine D3 Receptor Partial Agonism in Cariprazine-Induced Neurotransmitter Efflux in Rat Hippocampus and Nucleus Accumbens
- (2019) Mei Huang et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Blonanserin ameliorates social deficit through dopamine-D3 receptor antagonism in mice administered phencyclidine as an animal model of schizophrenia
- (2019) Saori Takeuchi et al. NEUROCHEMISTRY INTERNATIONAL
- Cariprazine in Youth with Bipolar and Psychotic Disorders: A Retrospective Chart Review
- (2019) Ethan A. Poweleit et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Initial Clinical Experience of RP5063 Following Single Doses in Normal Healthy Volunteers and Multiple Doses in Patients with Stable Schizophrenia
- (2018) Marc Cantillon et al. CTS-Clinical and Translational Science
- Neuropsychiatric disease–associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes
- (2018) Freja Herborg et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder
- (2018) Nermin Eissa et al. Frontiers in Neuroscience
- A fresh look at cortical dopamine D2 receptor expressing neurons
- (2018) Clémentine Quintana et al. PHARMACOLOGICAL RESEARCH
- Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology
- (2017) Oliver D Howes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial
- (2017) György Németh et al. LANCET
- Dopamine serotonin stabilizer RP5063: A randomized, double-blind, placebo-controlled multicenter trial of safety and efficacy in exacerbation of schizophrenia or schizoaffective disorder
- (2017) Marc Cantillon et al. SCHIZOPHRENIA RESEARCH
- Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review
- (2016) K. Jobski et al. ACTA PSYCHIATRICA SCANDINAVICA
- The dopamine D 3 -preferring D 2 /D 3 dopamine receptor partial agonist, cariprazine, reverses behavioural changes in a rat neurodevelopmental model for schizophrenia
- (2016) David J.G. Watson et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Weight Gain Effects of Second-Generation Antipsychotic Treatment in Autism Spectrum Disorder
- (2016) Yesie Yoon et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Dopaminergic Neurotransmission in the Nucleus Accumbens Modulates Social Play Behavior in Rats
- (2016) Antonia Manduca et al. NEUROPSYCHOPHARMACOLOGY
- The neurobiology of social play and its rewarding value in rats
- (2016) Louk J.M.J. Vanderschuren et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [11C]-(+)-PHNO
- (2016) Ragy R. Girgis et al. PSYCHOPHARMACOLOGY
- Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study
- (2016) Marco Lamberti et al. PEDIATRIC DRUGS
- Dopamine D3 Receptors Inhibit Hippocampal Gamma Oscillations by Disturbing CA3 Pyramidal Cell Firing Synchrony
- (2016) Clément E. Lemercier et al. Frontiers in Pharmacology
- DRD3 gene and striatum in autism spectrum disorder
- (2015) Wouter G. Staal et al. BRITISH JOURNAL OF PSYCHIATRY
- Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial
- (2015) Michael Aman et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Natural Neural Projection Dynamics Underlying Social Behavior
- (2014) Lisa A. Gunaydin et al. CELL
- Practice Parameter for the Assessment and Treatment of Children and Adolescents With Autism Spectrum Disorder
- (2014) Fred Volkmar et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- The place of dopamine in the cortico-basal ganglia circuit
- (2014) S.N. Haber NEUROSCIENCE
- Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission
- (2014) Gretchen L. Snyder et al. PSYCHOPHARMACOLOGY
- Use of aripiprazole and risperidone in children with autism: Effects of introducing an alternative new patented drug and debuting the first generic drug
- (2014) L. Wang et al. VALUE IN HEALTH
- Dopamine D3 receptor as a new pharmacological target for the treatment of depression
- (2013) Gian Marco Leggio et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs
- (2013) S Hong Lee et al. NATURE GENETICS
- Dopamine D3 receptor antagonism—still a therapeutic option for the treatment of schizophrenia
- (2013) Gerhard Gross et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care
- (2013) Macey L. Murray et al. PSYCHOPHARMACOLOGY
- The role of the striatum in social behavior
- (2013) Raymundo Báez-Mendoza et al. Frontiers in Neuroscience
- Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings
- (2012) Gabriel S Dichter et al. Journal of Neurodevelopmental Disorders
- Use of Psychotropic Medication in Children and Adolescents With Autism Spectrum Disorders
- (2012) Daniel L. Coury et al. PEDIATRICS
- The social motivation theory of autism
- (2012) Coralie Chevallier et al. TRENDS IN COGNITIVE SCIENCES
- Neurotransmitter systems and neurotrophic factors in autism: association study of 37 genes suggests involvement of DDC
- (2012) Claudio Toma et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Low-Dose Quetiapine for Adolescents With Autistic Spectrum Disorder and Aggressive Behavior
- (2011) Pavel Golubchik et al. CLINICAL NEUROPHARMACOLOGY
- Aripiprazole for the treatment of irritability associated with autism
- (2011) Cristan Ann Farmer et al. EXPERT OPINION ON PHARMACOTHERAPY
- Blockade of dopamine D3 but not D2 receptors reverses the novel object discrimination impairment produced by post-weaning social isolation: implications for schizophrenia and its treatment
- (2011) David J. G. Watson et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Contribution of SPECT Measurements of D2 and 5-HT2A Occupancy to the Clinical Development of the Antipsychotic SB-773812
- (2011) A. M. Catafau et al. JOURNAL OF NUCLEAR MEDICINE
- Human cognitive flexibility depends on dopamine D2 receptor signaling
- (2011) Mieke van Holstein et al. PSYCHOPHARMACOLOGY
- Reward processing in autism
- (2010) Ashley A. Scott-Van Zeeland et al. Autism Research
- Dopamine in Motivational Control: Rewarding, Aversive, and Alerting
- (2010) Ethan S. Bromberg-Martin et al. NEURON
- Psychopharmacology in autism: An update
- (2010) Roberto Canitano et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Getting specialized: presynaptic and postsynaptic dopamine D2 receptors
- (2009) Claudia De Mei et al. CURRENT OPINION IN PHARMACOLOGY
- Comparison of social cognitive functioning in schizophrenia and high functioning autism: more convergence than divergence
- (2009) S. M. Couture et al. PSYCHOLOGICAL MEDICINE
- A Common Variant in DRD3 Receptor Is Associated with Autism Spectrum Disorder
- (2008) Mariken de Krom et al. BIOLOGICAL PSYCHIATRY
- Quantitative Analysis of the Expression of Dopamine D1 and D2 Receptors in Pyramidal and GABAergic Neurons of the Rat Prefrontal Cortex
- (2008) N. Santana et al. CEREBRAL CORTEX
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started